These sections summarize the data on remdesivir, chloroquine, and other antiviral medications.
Review the Panel’s recommendations on the use of antiviral therapies in patients with COVID-19.
Remdesivir is a nucleotide analogue prodrug that is approved to treat COVID-19 in certain patients.
Read about using ritonavir-boosted nirmatrelvir in patients with COVID-19.
Read about using molnupiravir in patients with COVID-19.
Chloroquine and hydroxychloroquine are antimalarial drugs that were studied to treat COVID-19.
Interferons are a group of antiviral cytokines that are being evaluated to treat COVID-19.
Ivermectin is an antiparasitic drug that is being evaluated to treat COVID-19.
Protease inhibitors are antiretroviral drugs for HIV that were studied as treatments for COVID-19.
Nitazoxanide is an antiparasitic drug that is being evaluated to treat COVID-19.
This table summarizes key characteristics of antiviral agents that have been evaluated for COVID-19.